Venous Distension in Patients With Aneurysmatic Arterial Disease
1 other identifier
observational
98
0 countries
N/A
Brief Summary
The aim of the study is to assess if venous distension in patients with aneurysmatic arteriopathy is higher compared to patients with peripheral arterial occlusive disease (PAOD) and in controls.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started May 2016
Shorter than P25 for all trials
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 1, 2016
CompletedFirst Submitted
Initial submission to the registry
August 11, 2016
CompletedFirst Posted
Study publicly available on registry
August 16, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 28, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
March 28, 2017
CompletedApril 4, 2017
March 1, 2017
11 months
August 11, 2016
March 31, 2017
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Venous distension of > 27% in patients with aneurysmatic arterial disease
one year
Study Arms (3)
Aneurysmatic disease
Patients with dilatative arteriopathy (DA) the aortic diameter must be \> 3 cm or the popliteal artery diameter \> 1.5 cm
Peripheral arterial occlusive disease
Patients with arterial occlusive disease (PAOD) defined with an Ankle brachial index (ABI) \< 0.9 and positive criteria in the Edinburgh questionnaire.
Healthy
Control group of age matched persons without PAOD (ABI \> 0.9) and without DA.
Eligibility Criteria
The population is selected from patients of the angiologic clinic Baselland Bruderholz
You may qualify if:
- Patients with dilatative arteriopathy (DA) the aortic diameter must be \> 3 cm or the popliteal artery diameter \> 1.5 cm
- Patients with arterial occlusive disease (PAOD) defined with an Ankle brachial index (ABI) \< 0.9 and positive criteria in the Edinburgh questionnaire
- Patients able to give informed consent
- Control group of age matched persons without PAOD (ABI \> 0.9) and without DA
You may not qualify if:
- Impossibility to stand
- Diabetes
- No given informed consent
- Persons and patients \< 18 years old
- Acute deep venous thrombosis
- History of deep venous thrombosis
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Related Publications (2)
Jeanneret C, Baldi T, Hailemariam S, Koella C, Gewaltig J, Biedermann BC. Selective loss of extracellular matrix proteins is linked to biophysical properties of varicose veins assessed by ultrasonography. Br J Surg. 2007 Apr;94(4):449-56. doi: 10.1002/bjs.5630.
PMID: 17262753BACKGROUNDJeanneret C, Jager KA, Zaugg CE, Hoffmann U. Venous reflux and venous distensibility in varicose and healthy veins. Eur J Vasc Endovasc Surg. 2007 Aug;34(2):236-42. doi: 10.1016/j.ejvs.2007.03.018. Epub 2007 May 24.
PMID: 17524680BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- intern
Study Record Dates
First Submitted
August 11, 2016
First Posted
August 16, 2016
Study Start
May 1, 2016
Primary Completion
March 28, 2017
Study Completion
March 28, 2017
Last Updated
April 4, 2017
Record last verified: 2017-03